The SMid/ Large Cap Biotechnology Equity Research team covers companies spanning several areas including oncology, central nervous system disorders, and rare diseases. The lead analyst is top three ranked in the Institutional Investor vote for the smid biotech category. In 2021 the team worked on several priced IPOs and add ons and is currently vetting several additional transactions. The candidate for this position should be intellectually curious and have a deep desire to learn. The ideal candidate possesses a life science background and experience with financial modeling in either sell-side research or healthcare investment banking. He or she will work alongside the Senior Analyst and Associates in all aspects of the research process, from idea generation to modeling, including but not limited to the following:
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Industry
Credit Intermediation and Related Activities
Number of Employees
5,001-10,000 employees